Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

61results about How to "Produce toxicity" patented technology

Method for preparing injection level bio-based plastic from ferric sodium tartrate and glycerol-shielded wood powder hydroxyl

The invention relates to a method for preparing injection level bio-based plastic from ferric sodium tartrate and glycerol-shielded wood powder hydroxyl, which belongs to the field of bio-based plastic development. The purpose is to provide the bio-based plastic preparation method which is simple in process and low in production cost and can easily realize industrialization. Wood fiber material is ground, a ball mill is then used for ball-milling the material, so that powder is obtained, and the ball milling time is 4 to 15 hours. The wood fiber powder preprocessed by ball milling is added into a vessel in which ferric sodium tartrate solution is prepared, the mixture is swelled under a low temperature of 1 DEG C to 5 DEG C in a refrigerator, then keanded in a kneader at a cavity temperature of 30 DEG C to 80 DEG C for 3 to 6 hours and dried, so that an initial sample with certain thermoplasticity is obtained, glycerol, the part by weight of which is 5 to 40 percent, is added into the initial sample, and the initial sample is circulated in a double-screw extruder under the conditions of 50 DEG C to 140 DEG C in temperature and 30r/min to 110r/min in rotational speed for 5 to 60 minutes, and is then extruded out, so that the injection level bio-based plastic is obtained. The process of the method is simple, the resource utilization rate is high, and the obtained product has the advantages of high mechanical property, environment-friendliness, bio-degradability and the like.
Owner:NANJING FORESTRY UNIV

Bioadhesive type hollow microsphere and preparation method thereof

The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a bioadhesive type hollow microsphere of two alkalescent medicaments: dipyridamole and famotidine, and a preparation method thereof. The bioadhesive type hollow microsphere comprises medicaments, a skeleton material, a bioadhesive material, an emulsifying agent and a dispersing agent, wherein the preferred ratio of the medicaments to the skeleton material is 1 to (4-6). The bioadhesive type hollow microsphere is prepared by adopting an O/O emulsifying agent dispersion-volatilization method including the following steps: mixing the medicaments, the skeleton material and the bioadhesive type material weighed according to the amount of the prescription into an organic solvent, and stirring under low-temperature water bath condition for dissolving the medicaments, the skeleton material and the bioadhesive type material to obtain a dispersion phase; under the condition of 10DEG C water bath mechanical stirring, slowly dropwise adding the dispersion phase into liquid paraffin containing the emulsifying agent and the dispersing agent, performing low-temperature emulsification, heating and volatilizing to remove the organic solvent, separating, washing with n-hexane, drying and screening to obtain the bioadhesive type hollow microsphere. The prepared microsphere is high in encapsulation efficiency and yield, long in in-vivo retention time, and good in floatability, bioadhesion and slow-release property.
Owner:SHENYANG PHARMA UNIVERSITY

Multifunctional targeted ultrasound contrast agent and preparation method thereof

The invention discloses a multifunctional targeted ultrasound contrast agent. The contrast agent comprises carboxyl-terminated polylactic acid, wherein the carboxyl-terminated polylactic acid is filled with fluorocarbon gas to form carboxyl-terminated polylactic acid microspheres, the carboxyl-terminated polylactic acid loads Sudan black dye, and the carboxyl terminal of the carboxyl-terminated polylactic acid is coupled with an anti-human VEGFR-3 monoclonal antibody through a covalent bond. The contrast agent can more accurately and effectively perform positioning and be firmly combined on the surface of lymphatic endothelial cells, not only has strong target searching capability, but also has ultrasonic contrast imaging and intraoperative indication function, also has the function of preventing tumor metastasis, and is a multifunctional ultrasonic contrast agent with both blue staining trace effect and ultrasonic imaging effect and treatment. The invention also discloses a preparation method of the contrast agent, and the method utilizes a double emulsification method to prepare the ultrasonic contrast agent with the blue staining indication function, and uses EDC/ NHS as a coupling activator, and covalently connects VEGFR-3 on the surface of the ultrasonic contrast agent. The method is simple and easy to operate, and is suitable for large-scale production.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

Separation and culture method of umbilical cord blood derived mesenchymal stem cells

The invention discloses a separation and culture method of umbilical cord blood derived mesenchymal stem cells, and belongs to the technical field of biology. The separation and culture method comprises the following steps of performing centrifuging treatment on umbilical cord blood, taking an upper layer to obtain plasma, and taking a lower layer to obtain cells; performing inactivation treatmenton the plasma, then performing centrifuging treatment, and taking supernatant so as to obtain autoserum; mixing the lower-layer cells with normal saline to obtain a mixture, then placing the mixturein lymphocyte separation liquid, and performing centrifuging treatment so as to obtain umbilical cord blood mononuclear cells; and re-suspending the umbilical cord blood mononuclear cells with serum-free culture mediums, placing the re-suspended umbilical cord blood mononuclear cells in an autoserum coating culture dish, performing primary culture to obtain primary mesenchymal stem cells, adding cell dissociation liquid into the primary mesenchymal stem cells, performing cell dissociation treatment, and then performing subculturing. According to the method, penicllin-streptomycin for cell culture is not added in a separation process and a culture process, so that toxicity is not generated on the cells. In addition, according to the method, the autoserum coating culture dish for centrifugalseparation is adopted, so that animal derived viruses cannot be introduced.
Owner:陕西九州细胞基因工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products